Background: In addition to causing respiratory problems, patients with COVID-19 infection also present with neurological symptoms. We report neurological symptoms in a patient with severe COVID-19 infection admitted to the intensive care unit. Patients and Methods: We conducted a descriptive observational study from the patients treated in the intensive care unit (ICU) from October 2020 to September 2021 with neurological symptoms. Inclusion criteria for participants were patients who were confirmed positive for COVID-19 from the results of the nasopharyngeal polymerase chain reaction (PCR) swab, with neurological symptoms that appeared less ≤5 days before the results of the COVID-19 PCR swab were confirmed. Exclusion criteria were patients with negative PCR swab results, patients presenting with neurological symptoms >5 days before confirmed PCR, and patients with previously known neurological disorder. Results: A total of 160 COVID-19 patients were admitted to the ICU with neurological symptoms, consisting of 99 males (61.9%) and 61 females (38.1%). A total of 35 patients (21.9%) complained of headache, nine patients (5.6%) complained of vestibular disturbances, 23 patients (14.4%) with seizures, 88 patients (55%) with decreased consciousness (encephalopathy), nine patients with intracranial infection, 67 patients (41.9%) with stroke, and nine patients (5.6%) with movement disorders. Conclusion: The most common neurological symptom in severe COVID-19 patients treated in our ICU was decreased consciousness, followed by stroke and headache. Neurological symptoms found in patients with severe COVID-19 infection can be caused by direct viral infection or indirectly through the mechanism of severe hypoxia due to respiratory failure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.